BSGM
Get informed when a big investor buys or sells
+ FollowOvervalued by 100% based on the discounted cash flow analysis.
| Market cap | $191.13 Million |
|---|---|
| Enterprise Value | $184.27 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.07 |
| Beta | 1.82 |
| Outstanding Shares | 333,520,040 |
| P/E Ratio | -0.14 |
|---|---|
| PEG | -0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.35 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2940▼ 4.25% |
|---|---|
| Total Calls | 748,400▲ 123.63% |
| Total Puts | 220,000▲ 95.38% |
Holdings and activity of institutional investors.
| Ownership % | 7.07%▲ 3.44% |
|---|---|
| Total Invested | $26.65M▼ 27.47% |
| Investors Holding | 74▲ 10.00% |
No data
BioSig Technologies, Inc. recently rebranded as Streamex Corp., effective September 12, 2025, following its merger with Streamex Exchange Corporation. The company shifted focus from healthcare technology to real-world asset tokenization,...